EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie

Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas

Francesco Gaudio, Anna Mele, Eleonora Prete, Filomena Emanuela Laddaga, Alessandro Maggi, Nicola Di Renzo, Giuseppe Milone, Angelo Ostuni, Vincenzo Pavone

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-06103-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, 2024. Verfasst von Francesco Gaudio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, LUM University, Strada Statale 100, Km 18, 70010, Casamassima-Bari, Casamassima, BA, Italy. fragaudio@alice.it. Hauptthemen laut MEDLINE: Benzylamines, Lymphoma, Large B-Cell, Diffuse, Cyclams, Hematopoietic Stem Cell Mobilization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzylaminesLymphoma, Large B-Cell, DiffuseCyclamsHematopoietic Stem Cell MobilizationAntigens, CD34Heterocyclic CompoundsGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsHumansMiddle AgedMaleFemaleAgedAdultProspective StudiesRituximabDexamethasoneHematopoietic Stem Cell TransplantationPrednisoneEtoposide

Stichwörter der Autor:innen

ApheresisLymphoma, relapsing refractoryPoor mobilizationStem cell transplantation

Substanzen

plerixaforBenzylaminesCyclamsAntigens, CD34Heterocyclic CompoundsGranulocyte Colony-Stimulating FactorRituximabDexamethasonePrednisoneEtoposide

Autor:innen und Institutionen

  • Department of Medicine and Surgery, LUM University, Strada Statale 100, Km 18, 70010, Casamassima-Bari, Casamassima, BA, Italy. fragaudio@alice.it.
  • Hematology and Stem Cell Transplantation Unit, AOU Consorziale Policlinico, Bari, Italy. fragaudio@alice.it.
  • Hematology and Transplant Unit, "Cardinal Panico" Hospital, Tricase, LE, Italy.
  • Unit of Clinical Pathology, AOUC Policlinico, Bari, Italy.
  • Hematology Unit, Department of Hematology-Oncology, "Moscati" Hospital, Taranto, Italy.
  • Hematology and Stem Cell Transplant Unit, "Vito Fazzi" Hospital, Lecce, Italy.

Zitieren

APA

Gaudio, F., Mele, A., Prete, E., Laddaga, F. E., Maggi, A., Di Renzo, N., Milone, G., Ostuni, A., & Pavone, V. (2024). Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas. Annals of Hematology. https://doi.org/10.1007/s00277-024-06103-1

Vancouver

Gaudio F, Mele A, Prete E, Laddaga FE, Maggi A, Di Renzo N, et al. Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas. Annals of Hematology. 2024. doi:10.1007/s00277-024-06103-1

BibTeX
@article{Gaudio2024,
  author = {Gaudio, Francesco and Mele, Anna and Prete, Eleonora and Laddaga, Filomena Emanuela and Maggi, Alessandro and Di Renzo, Nicola and Milone, Giuseppe and Ostuni, Angelo and Pavone, Vincenzo},
  title = {Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-06103-1}
}
Kostenlos starten →